New test for ovarian cancer
A new screening test that tracks changing levels of a protein in the blood can detect twice as many ovarian cancers as conventional methods, research has shown.
The technique relies on a statistical calculation to interpret variations in the level of a protein called CA125 which is linked to ovarian cancer.
It gives a more accurate prediction of risk than the traditional diagnostic blood test which uses a fixed cut-off point for CA125.